Search for: "Sanofi-Aventis" Results 1 - 20 of 563
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Judge Appoints 2 LPR Attorneys to Leadership Roles in Insulin Pricing Multidistrict Litigation
7 Dec 2023, 6:00 am by Levin Papantonio
., and Sanofi-Aventis U.S. [read post]
Levin Papantonio Rafferty Law Firm - https://levinlaw.blogspot.com/
Article III and Seventh Amendment Challenges to Agency Adjudication in the Lower Courts, by Matthew Wiener & Jonathan Wiersema
24 Nov 2023, 6:08 pm by Guest Author
From Matthew Wiener: On November 29, 2023, the Supreme Court will hear argument in Securities and Exchange Commission v. [read post]
Notice & Comment - https://www.yalejreg.com/nc/
The UPC – a tale of multiple divisions
17 Nov 2023, 6:00 am by Gregory Bacon (Bristows)
The Amgen and Sanofi dispute is another case where proceedings are pending in multiple UPC fora, this time before the Central Division (Pari [read post]
Kluwer Patent Blog - http://patentblog.kluweriplaw.com/
JPML Centralizes Lawsuits Over Insulin Pricing Scheme
7 Aug 2023, 6:01 am by Levin Papantonio
., and Sanofi-Aventis U.S. [read post]
Levin Papantonio Rafferty Law Firm - https://levinlaw.blogspot.com/
Sanofi-Aventis Deutschlan GMBH v. Mylan Pharmaceuticals Inc.
2 Aug 2023, 11:05 am by Sofya Asatryan
The Federal Circuit reversed a Patent Trial and Appeal Board (“Board”) decision finding the challenged claims of Sanofi-Aventis’ ’614 patent unpatentable as obvious. [read post]
Intellectual Property Law Blog - http://www.intellectualpropertylawblog.com/
Recitation of a Previously Unappreciated Mechanism of Action Does Not Overcome Prima Facie Obviousness of Drug Combination
15 Jun 2023, 2:20 pm by Holman
., Sanofi-Aventis Deutschland GmbH v. [read post]
Patently-O - https://patentlyo.com
The “Inventive Step” in Analogous Prior Art
25 May 2023, 6:00 am by Brandon R. Theiss, Michael Barboun
In Sanofi-Aventis Deutschland GMBH v. [read post]
Imagine That IP Law Blog - https://www.vklaw.com/ImagineThatIPLawBlog
Petitioner’s Failure to Argue that Prior Art was Analogous to Challenged Patent Results in Reversal of IPR Decision
11 May 2023, 10:12 am by Holman
By Chris Holman Sanofi-Aventis Deutschland GMBH v. [read post]
Patently-O - https://patentlyo.com
"maximum strength" OTC claim plausibly misleading where prescription strength was stronger
6 Mar 2023, 5:06 am by Rebecca Tushnet
Sanofi-Aventis U.S. [read post]
43(B)log - http://tushnet.blogspot.com/
Resurrecting the Dead: Sanofi Aventis v. HHS
7 Feb 2023, 12:00 pm by Bernard Bell
Sanofi Adventis v. [read post]
Notice & Comment - https://www.yalejreg.com/nc/
Good Things Came in Threes for These Drug Companies: Three Judges at the Third Circuit Found for Three Drug Makers in 340B Contract Pharmacy Case
5 Feb 2023, 3:51 pm by Kurt R. Karst
AstraZeneca won in the District of Delaware, while Sanofi Aventis and Novo Nordisk lost at the District of New Jersey. [read post]
FDA Law Blog - https://www.thefdalawblog.com/
Mission Accomplia
4 Feb 2023, 5:28 pm by Ron Coleman
Per the EFF, Sanofi-Aventis backed down: “Under terms of Tuesday’s settlement, AcompliaReport.com keeps its domain name, as long as there is a disclaimer stating... [read post]
Likelihood of Confusion - http://www.likelihoodofconfusion.com
Tenth Circuit Refuses to Inject Consumer Choice Framework into Antitrust Challenge to EpiPen Distribution
1 Nov 2022, 7:50 am by Zak Gowen
Court of Appeals for the Tenth Circuit in Sanofi-Aventis U.S. v. [read post]
Antitrust Today - https://constantinecannon.com/practice/antitrust-litigation-counseling/antitrust-today/
Brief Amicus Curiae in Support of Appellees
18 Jul 2022, 2:00 am by Katharine Van Tassel
.), Sanofi-Aventis U.S., LLC v. [read post]
Health Law Prof Blog - https://lawprofessors.typepad.com/healthlawprof_blog/
ACI Paragraph IV Disputes Conference
13 Mar 2022, 8:56 pm by Patent Docs
The conference will open with an introduction by Co-Chairs Stephanie Donahue from Sanofi-Aventis and Lars Taavola from Mallinckrodt Pharmaceuticals. [read post]
Patent Docs - http://www.patentdocs.org/
Sanofi Aventis DEUTSCHLAND GMBH loses appeal at CAFC
29 Dec 2021, 4:16 pm by Lawrence B. Ebert
The outcome For the foregoing reasons, we affirm the four final written decisions that determined unpatentability based on Steenfeldt-Jensen: IPR2018-01670, IPR2018-01676, IPR2018-01678, and IPR2019-00979. [read post]
IPBiz - http://ipbiz.blogspot.com/
Zantac Lawsuit Settlement Payouts
28 Sep 2021, 7:37 am by Ronald V. Miller, Jr.
But projecting settlement amounts is what stock analysts and shareholders for Sanofi-Aventis, Boehringer Ingelheim, Pfizer, and GlaxoSmithKline are already doing and baking those costs into the stock price. [read post]
Lawsuit Information Center Blog - https://www.lawsuit-information-center.com/
Patentee doublethink in regulatory submissions and patent prosecution is inequitable conduct: Belcher v. Hospira (US)
23 Sep 2021, 2:10 am by Rose Hughes
Inequitable conduct includes, for example, intentionally failing to disclose information to the USPTO that is material to the patentability of an application (see also Sanofi-Aventis v Hospira, IPKat). [read post]
IPKat - http://ipkitten.blogspot.com/
prescription and OTC products can directly compete; many non-FDCA-based claims survive
9 Aug 2021, 2:22 pm by Rebecca Tushnet
Sanofi-Aventis U.S. [read post]
43(B)log - http://tushnet.blogspot.com/
CAFC Denies Amgen Petition to Reconsider Enablement Test for Biotech Patents
25 Jun 2021, 4:15 am by Logan Murr
(Amgen) in their case against Sanofi, Aventisub LLC, FKA Aventis Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., and Sanofi-Aventis U.S. [read post]
IPWatchdog - http://www.ipwatchdog.com/